Navigation Links
Genoptix Reports Strong Financial Results For Third Quarter 2007
Date:12/12/2007

U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release regarding the Company's business that are not historical facts may be considered "forward-looking statements," including statements regarding the value of the Company's services, the success of the Company's business model, the Company's ability to consistently provide specialized, dedicated and high quality services, the Company's growth prospects, DSOs, and the Company's financial guidance for 2007 and 2008. Forward-looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties, which may cause the Company's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from the results predicted include, without limitation, commercial and governmental reimbursement decisions, compliance and regulatory risks and the Company's ability to hire personnel and manage its growth and the competitive landscape within our industry. Certain other risks and uncertainties are detailed in the final prospectus for the Company's initial public offering that was filed with the United States Securities and Exchange Commission on October 30, 2007, and in its quarterly report on Form 10-Q for the quarterly period ended September 30, 2007. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Genoptix undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

GENOPTIX, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except par value)

September 30, December 31,


'/>"/>

SOURCE Genoptix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Gene Specific siRNA Controls , ... in siRNA , research or you ... convenience of the Silencer gene specific siRNA , ... contains 50 g of ready-to-use chemically synthesized and gel , ...
... , experiment depends ... expression vehicles (plasmids, PCR fragments) into cells. Many , ... reagents to deliver ... cells. The choice of reagent and the conditions under which it , ...
... Fluorescence activated cell sorting (FACS) is a , ... , individual cells using fluorescent probes that bind specifically ... is commonly used to collect , cells of a ... , Figure 1.Linear Amplification from 1-1000 Cells. ...
Cached Biology Technology:Control Your siRNA Research 2Control Your siRNA Research 3Choose the Right Transfection Agent for Your RNAi Experiment 2Choose the Right Transfection Agent for Your RNAi Experiment 3Choose the Right Transfection Agent for Your RNAi Experiment 4Choose the Right Transfection Agent for Your RNAi Experiment 5Choose the Right Transfection Agent for Your RNAi Experiment 6Choose the Right Transfection Agent for Your RNAi Experiment 7Cells-to-cDNA II Using FACS Sorted Cells 2
(Date:4/15/2014)... Reserve University dental researchers have found a less ... from the mouth to study how the mouth,s ... By isolating some specialized immune cells (white blood ... fight diseases in the mouthor reject foreign tissues, ... learn more about treating and preventing such health ...
(Date:4/15/2014)... form could help reduce side effects by targeting the ... have developed nanoparticles that deliver one or two chemotherapy ... particles that can carry any more than that in ... a new way to build such nanoparticles, making it ... In a paper published in the Journal of ...
(Date:4/15/2014)... By 2050, deforestation could cause temperatures in the ... increase would intensify warming caused by greenhouse gases ... at the University of Leuven, Belgium. , Explosive ... large-scale destruction of tropical rainforests in Central Africa. ... Leuven examined how these practices will affect longer-term ...
Breaking Biology News(10 mins):New method isolates immune cells for researchers to study how they ward off oral diseases 2Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Study: Deforestation could intensify climate change in Congo Basin by half 2
... finger as hard as you can against the surface. Now ... follow the ticking clock. Now faster. Now faster." These ... casts doubt on old ideas about mechanisms to control hand ... manual dexterity is so vulnerable to aging and disease, and ...
... developed salt-tolerant plants using a new type of genetic modification ... The research team based at the University of ... GM technique to contain salt in parts of the plant ... which means the results of this research could impact on ...
... 7, 2009) -- The Wildlife Conservation Society (WCS) announced today ... of the Amazon in Brazil. The monkey is related to ... their distinctively marked backs. The newly described distinct subspecies ... the state of Amazonas in northwestern Brazil. The discovery was ...
Cached Biology News:1-finger exercise reveals unexpected limits to dexterity 21-finger exercise reveals unexpected limits to dexterity 3Scientists closer to developing salt-tolerant crops 2New monkey discovered in Brazil 2
Request Info...
... Freezer Inventory Storage Racks for Standard ... to fit all makes and models ... Made of high quality stainless steel ... fiberboard, stainless steel or plastic boxes. ...
Immunogen: Recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies from E. coli and purified by preparative SDS-PAGE. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Chlorine-36, 3.7 MBq, 100 uCi. 0.1-0.3 HCl.< 111 MBq/g Cl, < 3 mCi/g Cl.Dispensed to order. Please inquire for alternative pack sizes. Category: Radiochemicals &Radiation Safety, Radiochemicals....
Biology Products: